TGF-β acting as an important tumor promoter, particularly at late stages of tumor development, is evidenced by using murine animal models and human cellular systems [7–10], in which TGF-β signaling components are required for tumor invasion in vitro and metastasis in vivo. The gene discussed is TGFB1; the disease is neoplasm.